Literature DB >> 18412402

Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategy.

Parmeswaran Diagaradjane1, Anil Shetty, James C Wang, Andrew M Elliott, Jon Schwartz, Shujun Shentu, Hee C Park, Amit Deorukhkar, R Jason Stafford, Sang H Cho, James W Tunnell, John D Hazle, Sunil Krishnan.   

Abstract

We report noninvasive modulation of in vivo tumor radiation response using gold nanoshells. Mild-temperature hyperthermia generated by near-infrared illumination of gold nanoshell-laden tumors, noninvasively quantified by magnetic resonance temperature imaging, causes an early increase in tumor perfusion that reduces the hypoxic fraction of tumors. A subsequent radiation dose induces vascular disruption with extensive tumor necrosis. Gold nanoshells sequestered in the perivascular space mediate these two tumor vasculature-focused effects to improve radiation response of tumors. This novel integrated antihypoxic and localized vascular disrupting therapy can potentially be combined with other conventional antitumor therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18412402      PMCID: PMC3952070          DOI: 10.1021/nl080496z

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  37 in total

Review 1.  Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.

Authors:  Khaled Greish
Journal:  J Drug Target       Date:  2007 Aug-Sep       Impact factor: 5.121

Review 2.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Hyperthermic radiosensitization: mode of action and clinical relevance.

Authors:  H H Kampinga; E Dikomey
Journal:  Int J Radiat Biol       Date:  2001-04       Impact factor: 2.694

Review 4.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

Authors:  M Höckel; P Vaupel
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

5.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 6.  Transport of molecules, particles, and cells in solid tumors.

Authors:  R K Jain
Journal:  Annu Rev Biomed Eng       Date:  1999       Impact factor: 9.590

7.  Tumor hypoxia in cancer therapy.

Authors:  J Martin Brown
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

Review 8.  Nanoparticles in cancer therapy and diagnosis.

Authors:  Irène Brigger; Catherine Dubernet; Patrick Couvreur
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

Review 9.  Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment.

Authors:  Benjamin J Moeller; Rachel A Richardson; Mark W Dewhirst
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

Review 10.  Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.

Authors:  Willem J van Heeckeren; Sharon L Sanborn; Ajita Narayan; Matthew M Cooney; Keith R McCrae; Alvin H Schmaier; Scot C Remick
Journal:  Curr Opin Hematol       Date:  2007-09       Impact factor: 3.284

View more
  51 in total

1.  Depth profiling of photothermal compound concentrations using phase sensitive optical coherence tomography.

Authors:  Guangying Guan; Roberto Reif; Zhihong Huang; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2011-12       Impact factor: 3.170

Review 2.  Development and applications of photo-triggered theranostic agents.

Authors:  Prakash Rai; Srivalleesha Mallidi; Xiang Zheng; Ramtin Rahmanzadeh; Youssef Mir; Stefan Elrington; Ahmat Khurshid; Tayyaba Hasan
Journal:  Adv Drug Deliv Rev       Date:  2010-09-19       Impact factor: 15.470

3.  Mild hyperthermia enhances transport of liposomal gemcitabine and improves in vivo therapeutic response.

Authors:  Dickson K Kirui; Christian Celia; Roberto Molinaro; Shyam S Bansal; Donato Cosco; Massimo Fresta; Haifa Shen; Mauro Ferrari
Journal:  Adv Healthc Mater       Date:  2015-02-26       Impact factor: 9.933

4.  Magnetic resonance temperature imaging validation of a bioheat transfer model for laser-induced thermal therapy.

Authors:  D Fuentes; C Walker; A Elliott; A Shetty; J D Hazle; R J Stafford
Journal:  Int J Hyperthermia       Date:  2011       Impact factor: 3.914

Review 5.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

Review 6.  A Review of Clinical Translation of Inorganic Nanoparticles.

Authors:  Aaron C Anselmo; Samir Mitragotri
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

7.  Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Authors:  Maryam Hajfathalian; Ahmad Amirshaghaghi; Pratap C Naha; Peter Chhour; Jessica C Hsu; Keely Douglas; Yuxi Dong; Chandra M Sehgal; Andrew Tsourkas; Svetlana Neretina; David P Cormode
Journal:  Nanoscale       Date:  2018-10-02       Impact factor: 7.790

8.  Cooperative nanomaterial system to sensitize, target, and treat tumors.

Authors:  Ji-Ho Park; Geoffrey von Maltzahn; Mary Jue Xu; Valentina Fogal; Venkata Ramana Kotamraju; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

9.  In vitro photothermal study of gold nanoshells functionalized with small targeting peptides to liver cancer cells.

Authors:  Shun-Ying Liu; Zhong-Shi Liang; Feng Gao; Shu-Fang Luo; Guo-Quan Lu
Journal:  J Mater Sci Mater Med       Date:  2009-10-16       Impact factor: 3.896

Review 10.  Nanotechnology in head and neck cancer: the race is on.

Authors:  Ivan H El-Sayed
Journal:  Curr Oncol Rep       Date:  2010-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.